Avacopan Better than Prednisone for Patients with AAV, Study Shares
freegr / Pixabay

Avacopan Better than Prednisone for Patients with AAV, Study Shares

Recently, the American College of Rheumatology (ACR) virtually held ACR Convergence 2020, the organization's annual meeting. At the meeting, researchers shared new insights in the realm of rheumatology; these were…

Continue Reading Avacopan Better than Prednisone for Patients with AAV, Study Shares
EMA Approves MAA Review of Avacopan for ANCA-Associated Vasculitis
source: pixabay.com

EMA Approves MAA Review of Avacopan for ANCA-Associated Vasculitis

On November 3, 2020, biopharmaceutical company ChemoCentryx and global pharmaceutical company Vifor Pharma Group's sub-business Vifor Fresenius Medical Care Renal Pharma (VFMCRP) announced that the European Medicines Agency will review…

Continue Reading EMA Approves MAA Review of Avacopan for ANCA-Associated Vasculitis
Patients with High ANCA Antibody Levels Have Greater Risk of AAV Relapse
source: pixabay.com

Patients with High ANCA Antibody Levels Have Greater Risk of AAV Relapse

In a recent study published in Clinical and Experimental Immunology, researchers determined that patients with high ANCA antibody levels are at an increased risk of having ANCA-associated vasculitis (AAV) relapses. According…

Continue Reading Patients with High ANCA Antibody Levels Have Greater Risk of AAV Relapse
New Test for Diagnosing ANCA Vasculitis Now Available
source: pixabay.com

New Test for Diagnosing ANCA Vasculitis Now Available

According to a story from GlobeNewswire, Exagen, Inc. recently launched a testing panel called AVISE® Vasculitis AAV, which is designed to help physicians get fast and accurate data for patients…

Continue Reading New Test for Diagnosing ANCA Vasculitis Now Available
FDA Accepts Avacopan NDA for ANCA-Associated Vasculitis
source: pixabay.com

FDA Accepts Avacopan NDA for ANCA-Associated Vasculitis

In a recent press release, biopharmaceutical company ChemoCentryx announced FDA approval for a New Drug Application (NDA) for avacopan, a treatment for ANCA-associated vasculitis. According to the FDA, a New…

Continue Reading FDA Accepts Avacopan NDA for ANCA-Associated Vasculitis
New Drug Application Submitted for Non-Steroidal ANCA-Associated Vasculitis Treatment
source: pixabay.com

New Drug Application Submitted for Non-Steroidal ANCA-Associated Vasculitis Treatment

ChemoCentryx has just announced that they have submitted their New Drug Application to the FDA for a novel ANCA-associated vasculitis therapy. It is called avacopan and it's finally something non-steroidal.…

Continue Reading New Drug Application Submitted for Non-Steroidal ANCA-Associated Vasculitis Treatment
The FDA Approves First Pediatric Treatment for Rare Forms of Vasculitis
qimono / Pixabay

The FDA Approves First Pediatric Treatment for Rare Forms of Vasculitis

According to a story from finanzen.ch, the US Food and Drug Administration (FDA) recently approved the drug rituximab (marketed as Rituxan) as a treatment in child patients aged at least…

Continue Reading The FDA Approves First Pediatric Treatment for Rare Forms of Vasculitis
Study Highlights Need for More Effective ANCA Vasculitis Classification
Belova59 / Pixabay

Study Highlights Need for More Effective ANCA Vasculitis Classification

According to a story from ANCA Vasculitis News, a recent study from Spain is highlighting the need for an updated classification system for ANCA-associated vasculitis that can predict patient prognosis…

Continue Reading Study Highlights Need for More Effective ANCA Vasculitis Classification
First Major Treatment Advance for PV Has Been Approved by the FDA
Source: pixabay.com

First Major Treatment Advance for PV Has Been Approved by the FDA

  According to BioSpace, a new treatment for pemphigus vulgaris (PV) has been recently approved by the U.S. Food and Drug Administration. The treatment, Rituxan (rituximab), is geared towards adults who have…

Continue Reading First Major Treatment Advance for PV Has Been Approved by the FDA
Is Bronchiectasis Related to Autoimmune Inflammatory Disease?
source: pixabay.com

Is Bronchiectasis Related to Autoimmune Inflammatory Disease?

According to a story from Bronchiectasis News Today, the results of a new study suggests that bronchiectasis may trigger autoimmune inflammatory disease. The study found that the condition was frequently…

Continue Reading Is Bronchiectasis Related to Autoimmune Inflammatory Disease?
This Amazing Preschool Teacher Donated Her Kidney to Her Student with MPA
https://pixabay.com/en/board-school-task-auto-task-2161880/

This Amazing Preschool Teacher Donated Her Kidney to Her Student with MPA

A year after 4-year-old Lyla was diagnosed with microscopic polyangiitis (MPA) in 2015, the disease became so advanced that she was placed on dialysis for 12 hours a day. Her…

Continue Reading This Amazing Preschool Teacher Donated Her Kidney to Her Student with MPA
Close Menu